In this article (9 sections)
Perimenopause is the transitional stretch of years leading up to menopause itself. It typically begins for women somewhere in their mid-to-late 40s, can start earlier, and lasts on average four to eight years before periods stop entirely. The defining feature is not falling estrogen so much as fluctuating estrogen and progesterone, which can produce a different hair picture than the post-menopausal state covered on the menopause page.
If you have noticed your hair getting thinner, your part getting wider, or your shedding becoming more variable in your 40s or early 50s, this stretch of life is one of the more common backdrops, and one of the most commonly misread.
What's happening hormonally
In a typical reproductive cycle, estrogen and progesterone rise and fall in a relatively predictable pattern across the month. In perimenopause, ovarian function becomes erratic. Estrogen can spike high in some cycles and dip low in others. Progesterone is often the first hormone to fall consistently as ovulation becomes less regular. Cycles may shorten, lengthen, become heavier, or become lighter, often varying month to month.
For hair, two consequences matter:
- Estrogen helps keep follicles in the growth phase. When estrogen drops, even temporarily, more follicles can cycle into the resting phase and shed three months later.
- The relative balance of estrogen to androgens shifts. Androgens (including testosterone and its more potent derivative DHT) do not necessarily rise in absolute terms, but their effect on the follicle becomes more pronounced as the estrogen counterweight weakens. In women with genetic susceptibility, this is often when female pattern hair loss begins to reveal itself.
What perimenopause hair loss tends to look like
The picture varies. Common patterns include:
- Episodes of telogen effluvium, where shedding ramps up for two to four months at a time, often after a particularly volatile stretch of cycles, then settles.
- Gradual diffuse thinning across the top of the scalp, especially noticeable as a widening part. This is the pattern most consistent with emerging female pattern hair loss.
- Texture change: hair feeling drier, finer, or less able to hold length, as individual strand diameters slowly reduce.
- Combined picture, where pattern thinning is the underlying trend and episodic shedding sits on top of it.
Because shedding can come in waves, it is easy to assume each episode is a fresh, isolated trigger (a stressful month, a viral illness, a poor stretch of sleep) rather than part of a longer hormonal shift.
How this differs from menopause itself
Once a woman has gone twelve consecutive months without a period, she is by definition postmenopausal. At that point, estrogen and progesterone have settled at low, stable levels. Shedding driven by hormonal volatility tends to ease, while the underlying female pattern tendency continues to progress slowly unless treated.
In short: perimenopause is the volatile window; menopause is the new steady state. The shedding episodes that characterize perimenopause typically settle, but any pattern thinning that emerged during this window usually requires its own treatment plan, since it does not reverse on its own.
Other contributors common in this age window
Perimenopause overlaps in age with several other hair-relevant conditions, and it is worth checking that one isn't being missed:
- Thyroid disease. The incidence of thyroid disorders rises in midlife, and hypothyroidism in particular can drive diffuse shedding that mimics hormonal change.
- Iron deficiency. Heavy or unpredictable perimenopausal periods can deplete iron stores. See the iron deficiency page for ferritin targets and supplementation.
- Stress and sleep disruption. Night sweats, anxiety, and broken sleep are themselves perimenopausal symptoms and can contribute to stress-related shedding.
- Medication changes. Starting or stopping hormonal contraception, hormone therapy, or other medications can produce shedding three months later, independent of the underlying hormonal transition.
What to evaluate
A reasonable initial evaluation for shedding in a woman in her 40s or early 50s often includes:
- TSH and free T4 for thyroid
- Ferritin and a CBC for iron stores and anemia
- Vitamin D (25-hydroxyvitamin D)
- A clinical look at the scalp pattern to distinguish diffuse shedding from emerging female pattern thinning
- History of cycles, menopausal symptoms, medications, and stressors to put the timing in context
Hormone panels (FSH, estradiol) can confirm perimenopause but vary so much cycle-to-cycle that they are not always required to make the call clinically.
Treatment considerations during this window
Approach depends on what is driving the shedding. Acute episodes of telogen effluvium often resolve on their own once the trigger settles, with hair returning over six to nine months. Pattern thinning that emerges during this window is unlikely to reverse on its own and is generally addressed with options like topical minoxidil when medically appropriate, with the women's treatment options page covering the full picture, including the role of oral medications used off-label in women.
Hormone therapy decisions sit with a woman's primary care or gynecology team rather than a hair-focused visit. Whether hormone therapy helps perimenopausal shedding specifically is not well established; it is typically prescribed for other menopausal symptoms.
When to consider a medical assessment
If shedding has been going on for more than three months, if you are noticing a widening part or visible scalp where you did not before, or if you are uncertain whether the pattern fits hormonal volatility versus underlying pattern loss, a structured evaluation helps. A Curekey clinician can review history, screen for treatable contributors, and discuss whether treatment is appropriate. Start a free assessment, or read how it works before beginning.
Related reading
- Menopause hair loss
- Female pattern hair loss
- Hormonal causes of hair loss
- Thyroid disease and hair loss in women
- Iron deficiency and hair loss in women
- Treatment options for women
